{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T04:19:45Z","timestamp":1771301985495,"version":"3.50.1"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"University Grant Commission"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1016\/j.ejpb.2015.08.008","type":"journal-article","created":{"date-parts":[[2015,8,28]],"date-time":"2015-08-28T21:00:16Z","timestamp":1440795616000},"page":"363-379","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":64,"special_numbering":"C","title":["Intranasal microemulsion for targeted nose to brain delivery in neurocysticercosis: Role of docosahexaenoic acid"],"prefix":"10.1016","volume":"96","author":[{"given":"Rajshree L.","family":"Shinde","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gopal P.","family":"Bharkad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Padma V.","family":"Devarajan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejpb.2015.08.008_b0005","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0168-3659(02)00363-2","article-title":"Nasal drug delivery: problems, possibilities and solutions","volume":"87","author":"Illum","year":"2003","journal-title":"J. Control. Rel."},{"key":"10.1016\/j.ejpb.2015.08.008_b0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijpharm.2007.03.025","article-title":"Intranasal delivery: physicochemical and therapeutic aspects","volume":"337","author":"Costantino","year":"2007","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2015.08.008_b0015","series-title":"Advanced Anticancer Approaches with Multifunctional Lipid Nanocarriers","first-page":"347","article-title":"Advances in microemulsions and nanoemulsions for improved therapy in brain cancer","author":"Devarajan","year":"2011"},{"key":"10.1016\/j.ejpb.2015.08.008_b0020","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.ejpb.2014.02.007","article-title":"Haloperidol-loaded intranasally administered lectin functionalized poly (ethylene glycol)\u2013block-poly (d,l)-lactic-co-glycolic acid (PEG\u2013PLGA) nanoparticles for the treatment of schizophrenia","volume":"87","author":"Piazza","year":"2014","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2015.08.008_b0025","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1097\/WAD.0b013e318157205b","article-title":"Intranasal mucoadhesive microemulsion of tacrine to improve brain targeting","volume":"22","author":"Jogani","year":"2008","journal-title":"Alzheimer Dis. Assoc. Disord."},{"key":"10.1016\/j.ejpb.2015.08.008_b0030","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/s13318-013-0171-8","article-title":"Pharmacokinetic evaluation of formulated levodopa methyl ester nasal delivery systems","volume":"39","author":"Lee","year":"2014","journal-title":"Eur. J. Drug Metabo. Pharmacokinet."},{"key":"10.1016\/j.ejpb.2015.08.008_b0035","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.ejpb.2012.10.010","article-title":"Influence of polymeric microcarriers on the in vivo intranasal uptake of an anti-migraine drug for brain targeting","volume":"83","author":"Gavini","year":"2013","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2015.08.008_b0040","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1038\/mt.2011.164","article-title":"Treatment of brain inflammatory diseases by delivering exosome encapsulated anti-inflammatory drugs from the nasal region to the brain","volume":"19","author":"Zhuang","year":"2011","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ejpb.2015.08.008_b0045","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1212\/01.wnl.0000238514.51747.3a","article-title":"Treatment of neurocysticercosis current status and future research needs","volume":"67","author":"Nash","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.ejpb.2015.08.008_b0050","doi-asserted-by":"crossref","first-page":"e2142","DOI":"10.1371\/journal.pntd.0002142","article-title":"The incidence of human cysticercosis in a rural community of Eastern Zambia","volume":"7","author":"Mwape","year":"2013","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.ejpb.2015.08.008_b0055","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1128\/AAC.00761-10","article-title":"Sensitive in vitro system to assess morphological and biochemical effects of praziquantel and albendazole on Taenia solium cysts","volume":"55","author":"Mahanty","year":"2011","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejpb.2015.08.008_b0060","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1093\/jac\/dki484","article-title":"Evaluation of the efficacy of albendazole sulphoxide and praziquantel in combination on Taenia crassiceps cysts: in vitro studies","volume":"57","author":"Palomares","year":"2006","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.ejpb.2015.08.008_b0065","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1093\/jac\/41.2.145","article-title":"Albendazole","volume":"41","author":"Venkatesan","year":"1998","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.ejpb.2015.08.008_b0070","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0169-409X(00)00103-4","article-title":"Microemulsion-based media as novel drug delivery systems","volume":"45","author":"Lawrence","year":"2000","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejpb.2015.08.008_b0075","doi-asserted-by":"crossref","first-page":"119","DOI":"10.2174\/157341311794480282","article-title":"Microemulsions and nanoemulsions for targeted drug delivery to the brain","volume":"7","author":"Shinde","year":"2011","journal-title":"Curr. Nanosci."},{"key":"10.1016\/j.ejpb.2015.08.008_b0080","doi-asserted-by":"crossref","first-page":"E49","DOI":"10.1208\/pt070108","article-title":"Preliminary brain-targeting studies on intranasal mucoadhesive microemulsions of sumatriptan","volume":"7","author":"Vyas","year":"2006","journal-title":"AAPS PharmSciTech."},{"key":"10.1016\/j.ejpb.2015.08.008_b0085","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1002\/jps.20480","article-title":"Intranasal mucoadhesive microemulsions of clonazepam: preliminary studies on brain targeting","volume":"95","author":"Vyas","year":"2006","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2015.08.008_b0090","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1080\/10611860802476504","article-title":"Mucoadhesive nanoemulsion-based intranasal drug delivery system of olanzapine for brain targeting","volume":"16","author":"Kumar","year":"2008","journal-title":"J. Drug Target."},{"key":"10.1016\/j.ejpb.2015.08.008_b0095","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.ijpharm.2008.03.029","article-title":"Intranasal nanoemulsion based brain targeting drug delivery system of risperidone","volume":"358","author":"Kumar","year":"2008","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2015.08.008_b0100","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1080\/10611860500246217","article-title":"Intranasal mucoadhesive microemulsions of zolmitriptan: preliminary studies on brain-targeting","volume":"13","author":"Vyas","year":"2005","journal-title":"J. Drug Target."},{"key":"10.1016\/j.ejpb.2015.08.008_b0105","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.ijpharm.2004.01.039","article-title":"Preparation of nimodipine-loaded microemulsion for intranasal delivery and evaluation on the targeting efficiency to the brain","volume":"275","author":"Zhang","year":"2004","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2015.08.008_b0110","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.ijpharm.2007.06.016","article-title":"Improved oral bioavailability and brain transport of Saquinavir upon administration in novel nanoemulsion formulations","volume":"347","author":"Vyas","year":"2008","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2015.08.008_b0115","doi-asserted-by":"crossref","first-page":"2510","DOI":"10.3945\/jn.108.096016","article-title":"Docosahexaenoic acid and the aging brain","volume":"138","author":"Lukiw","year":"2008","journal-title":"J. Nutr."},{"key":"10.1016\/j.ejpb.2015.08.008_b0120","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1124\/dmd.32.5.536","article-title":"Comparative hepatic and extrahepatic enantioselective sulfoxidation of albendazole and fenbendazole in sheep and cattle","volume":"32","author":"Virkel","year":"2004","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.ejpb.2015.08.008_b0125","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1089\/107555303321223035","article-title":"Safety and anti-inflammatory activity of curcumin: a component of tumeric (Curcuma longa)","volume":"9","author":"Chainani-Wu","year":"2003","journal-title":"J. Altern. Complement. Med."},{"key":"10.1016\/j.ejpb.2015.08.008_b0130","first-page":"266","article-title":"Formulation and evaluation of self-microemulsifying drug delivery system of lovastatin","volume":"5","author":"Patel","year":"2010","journal-title":"Asian J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2015.08.008_b0135","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.ejpb.2010.07.011","article-title":"Development and evaluation of self-microemulsifying liquid and pellet formulations of curcumin, and absorption studies in rats","volume":"76","author":"Setthacheewakul","year":"2010","journal-title":"Eur. J. Pharm. Biopham."},{"key":"10.1016\/j.ejpb.2015.08.008_b0140","doi-asserted-by":"crossref","first-page":"575","DOI":"10.2217\/nnm.10.28","article-title":"Formulation and evaluation of novel micellar nanocarrier for nasal delivery of sumatriptan","volume":"5","author":"Jain","year":"2010","journal-title":"Nanomedicine"},{"key":"10.1016\/j.ejpb.2015.08.008_b0145","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1556-276X-6-560","article-title":"Rheological non-Newtonian behaviour of ethylene glycol-based Fe2O3 nanofluids","volume":"6","author":"Pastoriza-Gallego","year":"2011","journal-title":"Nanoscale Res. Lett."},{"key":"10.1016\/j.ejpb.2015.08.008_b0150","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.ejpb.2007.01.010","article-title":"Mucoadhesive properties of various pectins on gastrointestinal mucosa: an in vitro evaluation using texture analyzer","volume":"67","author":"Thirawong","year":"2007","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2015.08.008_b0155","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1023\/A:1018987120738","article-title":"A novel assay to determine the hemolytic activity of drugs incorporated in colloidal carrier systems","volume":"11","author":"Bock","year":"1994","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejpb.2015.08.008_b0160","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.ejpb.2005.07.006","article-title":"Doxorubicin-encapsulated thermosensitive liposomes modified with poly (N-isopropylacrylamide-co-acrylamide): drug release behavior and stability in the presence of serum","volume":"62","author":"Han","year":"2006","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2015.08.008_b0165","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.carbpol.2012.08.077","article-title":"Thiolated xyloglucan: synthesis, characterization and evaluation as mucoadhesive in situ gelling agent","volume":"91","author":"Mahajan","year":"2013","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.ejpb.2015.08.008_b0170","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.jconrel.2014.06.053","article-title":"Quantitative analysis of drug delivery to the brain via nasal route","volume":"189","author":"Kozlovskaya","year":"2014","journal-title":"J. Control. Rel."},{"key":"10.1016\/j.ejpb.2015.08.008_b0175","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.ijpharm.2010.04.021","article-title":"Effects of polyamidoamine (PAMAM) dendrimers on the nasal absorption of poorly absorbable drugs in rats","volume":"393","author":"Dong","year":"2010","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2015.08.008_b0180","first-page":"10","article-title":"An effective manual deboning method to prepare intact mouse nasal tissue with preserved anatomical organization","volume":"78","author":"Dunston","year":"2013","journal-title":"J. Vis. Exp."},{"key":"10.1016\/j.ejpb.2015.08.008_b0185","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.bcp.2009.08.030","article-title":"Synergistic anti-inflammatory effects of low doses of curcumin in combination with polyunsaturated fatty acids: docosahexaenoic acid or eicosapentaenoic acid","volume":"79","author":"Saw","year":"2010","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejpb.2015.08.008_b0190","doi-asserted-by":"crossref","first-page":"323","DOI":"10.3109\/08982104.2014.899369","article-title":"Multifunctional liposomes for nasal delivery of the anti-Alzheimer drug tacrine hydrochloride","volume":"24","author":"Corace","year":"2014","journal-title":"J. Liposome Res."},{"key":"10.1016\/j.ejpb.2015.08.008_b0195","series-title":"Drug Absorption Studies: In Situ, In Vitro and In Silico Models","first-page":"216","article-title":"In vitro cellular models for nasal drug absorption studies","author":"Dae-Duk","year":"2007"},{"key":"10.1016\/j.ejpb.2015.08.008_b0200","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1021\/nl0805615","article-title":"Method for analysis of nanoparticle hemolytic properties in vitro","volume":"8","author":"Dobrovolskaia","year":"2008","journal-title":"Nano Lett."},{"key":"10.1016\/j.ejpb.2015.08.008_b0205","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s11010-005-9074-6","article-title":"Docosahexaenoic acid and eicosapentaenoic acid-enriched phosphatidylcholine liposomes enhance the permeability, transportation and uptake of phospholipids in Caco-2 cells","volume":"285","author":"Hossain","year":"2006","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.ejpb.2015.08.008_b0210","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/S0899-9007(02)00927-9","article-title":"Effect of \u03b3-linolenic acid or docosahexaenoic acid on tight junction permeability in intestinal monolayer cells and their mechanism by protein kinase C activation and\/or eicosanoid formation","volume":"19","author":"Usami","year":"2003","journal-title":"Nutrition"},{"key":"10.1016\/j.ejpb.2015.08.008_b0215","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.3945\/jn.109.120469","article-title":"Intracellular mechanisms involved in docosahexaenoic acid-induced increases in tight junction permeability in Caco-2 cell monolayers","volume":"140","author":"Roig-P\u00e9rez","year":"2010","journal-title":"J. Nutr."},{"key":"10.1016\/j.ejpb.2015.08.008_b0220","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.jconrel.2009.10.005","article-title":"Impact of emulsion-based drug delivery systems on intestinal permeability and drug release kinetics","volume":"142","author":"Buyukozturk","year":"2010","journal-title":"J. Control. Rel."},{"key":"10.1016\/j.ejpb.2015.08.008_b0225","doi-asserted-by":"crossref","first-page":"3","DOI":"10.4172\/2167-7956.1000e119","article-title":"Docosahexaenoic acid: a potential modulator of brain tumors and metastasis","volume":"2","author":"Siddiqui","year":"2013","journal-title":"J. Biomol. Res. Ther."},{"key":"10.1016\/j.ejpb.2015.08.008_b0230","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1007\/s12035-010-8131-7","article-title":"Targeting the brain and lipoxygenation","volume":"42","author":"Picq","year":"2010","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.ejpb.2015.08.008_b0235","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.ijpharm.2009.08.001","article-title":"Formulation of multifunctional oil-in-water nanosized emulsions for active and passive targeting of drugs to otherwise inaccessible internal organs of the human body","volume":"381","author":"Tamilvanan","year":"2009","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2015.08.008_b0240","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/nature13241","article-title":"Mfsd2a is a transporter for the essential omega-3 fatty acid docosahexaenoic acid","volume":"509","author":"Nguyen","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.ejpb.2015.08.008_b0245","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1080\/10611860290031877","article-title":"Apolipoprotein-mediated transport of nanoparticle-bound drugs across the blood-brain barrier","volume":"10","author":"Kreuter","year":"2002","journal-title":"J. Drug Target."},{"key":"10.1016\/j.ejpb.2015.08.008_b0250","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1023\/A:1022604120952","article-title":"Direct evidence that polysorbate-80-coated poly(butyl cyanoacrylate) nanoparticles deliver drugs to the CNS via specific mechanisms requiring prior binding of the drug to the nanoparticles","volume":"20","author":"Kreuter","year":"2003","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejpb.2015.08.008_b0255","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1080\/10611860500071292","article-title":"Polysorbate-stabilized solid lipid nanoparticles as colloidal carriers for intravenous targeting of drugs to the brain: comparison of plasma protein adsorption patterns","volume":"13","author":"Goppert","year":"2005","journal-title":"J. Drug Target."},{"key":"10.1016\/j.ejpb.2015.08.008_b0260","doi-asserted-by":"crossref","first-page":"5","DOI":"10.7243\/2050-120X-2-5","article-title":"B., Partial characterisation of alkaline phosphatase in Fasciolopsis buski \u2013 an intestinal fluke treated with crude extract of Alpinia nigra (Zingiberaceae)","volume":"2","author":"Swargiary","year":"2013","journal-title":"J. Pharm. Technol. Drug Res."},{"key":"10.1016\/j.ejpb.2015.08.008_b0265","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/cbf.1526","article-title":"Effects of arachidonic acid and docosahexaenoic acid on differentiation and mineralization of MC3T3-E1 osteoblast-like cells","volume":"27","author":"Coetzee","year":"2009","journal-title":"Cell Biochem. Funct."}],"container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641115003409?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641115003409?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,19]],"date-time":"2018-09-19T23:54:12Z","timestamp":1537401252000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939641115003409"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10]]},"references-count":53,"alternative-id":["S0939641115003409"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpb.2015.08.008","relation":{},"ISSN":["0939-6411"],"issn-type":[{"value":"0939-6411","type":"print"}],"subject":[],"published":{"date-parts":[[2015,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intranasal microemulsion for targeted nose to brain delivery in neurocysticercosis: Role of docosahexaenoic acid","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutics and Biopharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejpb.2015.08.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}